These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22915289)

  • 1. The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.
    Zada G; Tirosh A; Huang AP; Laws ER; Woodmansee WW
    Pituitary; 2013 Sep; 16(3):319-25. PubMed ID: 22915289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
    McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
    World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of routine postoperative morning cortisol monitoring in detecting new hypothalamic-pituitary-adrenal axis insufficiency following endoscopic transsphenoidal surgery for sellar lesions.
    Jackanich A; Tavakol S; Strickland BA; Rutkowski M; Kamel D; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2020 Apr; 132(4):1054-1058. PubMed ID: 30835697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UTILITY OF A GLUCOCORTICOID SPARING STRATEGY IN THE MANAGEMENT OF PATIENTS FOLLOWING TRANSSPHENOIDAL SURGERY.
    Jia X; Pendharkar AV; Loftus P; Dodd RL; Chu O; Fraenkel M; Katznelson L
    Endocr Pract; 2016 Sep; 22(9):1033-9. PubMed ID: 27124693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transphenoidal surgery without steroid replacement in patients with morning serum cortisol below 9 μg/dl (250 Nmol/l).
    De Tommasi C; Goguen J; Cusimano MD
    Acta Neurochir (Wien); 2012 Oct; 154(10):1903-15. PubMed ID: 22922981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MORNING SERUM CORTISOL LEVEL AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY ADENOMA PREDICTS HYPOTHALAMIC-PITUITARY-ADRENAL FUNCTION DESPITE INTRAOPERATIVE DEXAMETHASONE USE.
    Manuylova E; Calvi LM; Vates GE; Hastings C; Shafiq I
    Endocr Pract; 2015 Aug; 21(8):897-902. PubMed ID: 26121454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose ACTH test for evaluation of hypothalamus-pituitary-adrenal axis preoperatively and 3-month follow-up in non-functioning pituitary adenomas.
    Garg A; Mishra SK; Dubey S; Singh VP; Kuchay MS; Mithal A
    J Endocrinol Invest; 2020 Dec; 43(12):1769-1777. PubMed ID: 32436184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
    Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?
    Auchus RJ; Shewbridge RK; Shepherd MD
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):21-7. PubMed ID: 9059554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions.
    Prencipe N; Parasiliti-Caprino M; Gatti F; Penner F; Berton AM; Bona C; Caputo M; D'Angelo V; Cappiello V; Gasco V; Ghigo E; Zenga F; Grottoli S
    Neuroendocrinology; 2021; 111(7):639-649. PubMed ID: 32492678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical assessment of adrenal insufficiency after adrenalectomy for non-cortisol secreting tumors: clinical correlation and recommendations.
    Kahramangil B; Montorfano L; Gutierrez D; Erten O; Zhou K; Li D; Rao P; Berber E
    Surg Endosc; 2022 Oct; 36(10):7638-7646. PubMed ID: 35414133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a protocol for reduced glucocorticoid replacement in transsphenoidal pituitary adenomectomy: prophylactic glucocorticoid replacement is seldom necessary.
    Wentworth JM; Gao N; Sumithran KP; Maartens NF; Kaye AH; Colman PG; Ebeling PR
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):29-35. PubMed ID: 18088287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Random postoperative day-3 cortisol concentration as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgery.
    Khan MI; Habra MA; McCutcheon IE; Nogueras-González GM; Devin JK; Busaidy NL; Levine NB; Lindstrom W; Kagan D; Jimenez C; Waguespack SG
    Endocr Pract; 2011; 17(5):717-26. PubMed ID: 21454228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation.
    Marko NF; Gonugunta VA; Hamrahian AH; Usmani A; Mayberg MR; Weil RJ
    J Neurosurg; 2009 Sep; 111(3):540-4. PubMed ID: 19326985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamic-pituitary-adrenal axis before and after pituitary surgery?
    Karaca Z; Tanriverdi F; Atmaca H; Gokce C; Elbuken G; Selcuklu A; Unluhizarci K; Kelestimur F
    Eur J Endocrinol; 2010 Sep; 163(3):377-82. PubMed ID: 20530552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma.
    Kolnes AJ; Øystese KA; Dahlberg D; Berg-Johnsen J; Niehusmann P; Pahnke J; Bollerslev J; Jørgensen AP
    Acta Neurochir (Wien); 2020 Apr; 162(4):845-852. PubMed ID: 31907611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.
    Pimentel-Filho FR; Silva ME; Nogueira KC; Berger K; Cukiert A; Liberman B
    J Endocrinol Invest; 2005 Jun; 28(6):502-8. PubMed ID: 16117190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.